Orchestra BioMed (OBIO) director adds 5,000 shares in open-market buy

Rhea-AI Filing Summary

Orchestra BioMed Holdings, Inc. director and officer David P. Hochman reported an open-market purchase of 5,000 shares of Common Stock on May 15, 2026 at a weighted average price of $3.77 per share. Following this purchase, he directly holds 1,059,029 shares of Common Stock.

The filing also lists indirect holdings through several family trusts, including 439,482 shares held by the DPH 2008 Trust and smaller positions held by the NSH 2008 Family Trust and three 2019 trusts.

Insider Trade Summary

Net Buyer: 5,000 shares ($18,850)

Net Buy 6 txns

Insider Hochman David P

Role See Remarks

Bought 5,000 shs ($19K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $0.0001 per share ("Common Stock")	5,000	$3.77	$19K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock, par value $0.0001 per share ("Common Stock") — 1,059,029 shares (Direct, null); Common Stock — 439,482 shares (Indirect, By the DPH 2008 Trust)

Footnotes (1)

1. [object Object]

Key Figures

Shares purchased: 5,000 shares Purchase price: $3.77 per share Direct holdings after transaction: 1,059,029 shares +5 more

8 metrics

Shares purchased 5,000 shares Open-market purchase on May 15, 2026

Purchase price $3.77 per share Weighted average price, range $3.75–$3.79

Direct holdings after transaction 1,059,029 shares Common Stock directly owned after May 15, 2026 trade

DPH 2008 Trust holdings 439,482 shares Indirect ownership via DPH 2008 Trust

NSH 2008 Family Trust holdings 3,140 shares Indirect ownership via NSH 2008 Family Trust

Judah Herman Hochman 2019 Trust holdings 2,000 shares Indirect ownership via 2019 trust

Hannah Hochman 2019 Trust holdings 2,000 shares Indirect ownership via 2019 trust

Solomon Ascher Hochman 2019 Trust holdings 2,000 shares Indirect ownership via 2019 trust

Key Terms

open-market purchase, weighted average price, indirect ownership, family trust, +1 more

5 terms

open-market purchase financial

"reported an open-market purchase of 5,000 shares of Common Stock"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

weighted average price financial

"The price reported is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

indirect ownership financial

"Indirect holdings through several family trusts"

family trust financial

"holdings through several family trusts, including the DPH 2008 Trust"

Common Stock financial

"purchase of 5,000 shares of Common Stock on May 15, 2026"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hochman David P

(Last) (First) (Middle)

C/O ORCHESTRA BIOMED HOLDINGS, INC.

150 UNION SQUARE DRIVE

(Street)

NEW HOPE PENNSYLVANIA 18938

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Orchestra BioMed Holdings, Inc. [ OBIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001 per share ("Common Stock")	05/15/2026		P		5,000	A	$3.77(1)	1,059,029	D
Common Stock								439,482	I	By the DPH 2008 Trust
Common Stock								2,000	I	By the Solomon Ascher Hochman 2019 Trust
Common Stock								2,000	I	By the Hannah Hochman 2019 Trust
Common Stock								2,000	I	By the Judah Herman Hochman 2019 Trust
Common Stock								3,140	I	By the NSH 2008 Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.75 to $3.79. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Remarks:

Chief Executive Officer and Chairperson

	/s/ Andrew Taylor, Attorney-in-Fact	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did OBIO director David P. Hochman report?

David P. Hochman reported an open-market purchase of 5,000 shares of Orchestra BioMed Holdings Common Stock. The transaction occurred on May 15, 2026 at a weighted average price of $3.77 per share, reflecting additional personal investment in the company’s stock.

At what price did David P. Hochman buy OBIO shares in this Form 4?

He purchased the 5,000 Orchestra BioMed Holdings shares at a weighted average price of $3.77. The footnote explains that the trades were executed in multiple lots between $3.75 and $3.79 per share, with full breakdowns available upon request.

How many OBIO shares does David P. Hochman hold directly after this transaction?

After the reported purchase, David P. Hochman directly holds 1,059,029 shares of Orchestra BioMed Holdings Common Stock. This figure reflects his direct ownership position as of the May 15, 2026 transaction date disclosed in the Form 4 filing.

What indirect Orchestra BioMed (OBIO) holdings are reported for David P. Hochman?

The filing lists several indirect holdings through family trusts, including 439,482 shares held by the DPH 2008 Trust and smaller positions of 3,140, 2,000, 2,000, and 2,000 shares in the NSH 2008 Family Trust and three 2019 trusts named for family members.

Does the OBIO Form 4 show any insider sales by David P. Hochman?

The Form 4 reports one open-market purchase totaling 5,000 shares and no sales. The transactionSummary shows a buyCount of one, sellCount of zero, and a net-buy direction based on 5,000 net buy-sell shares for this reporting period.